Cough Medicine Shows a Hint of Promise in Parkinson's Dementia

Cough Medicine Shows a Hint of Promise in Parkinson's Dementia

(MedPage Today) -- Ambroxol, a common cough medicine used in Europe, demonstrated target engagement in people with Parkinson's disease dementia but did not show an effect on cognition compared with placebo, a year-long phase II trial showed. Looking...

A cough medicine could hold new hope in the fight against dementia; research

decades-old cough medicine could hold new hope in the fight against dementia.

Euro Cough Medicine Shows Promise in Parkinson's Dementia | Drug Discovery And Development

A cough medicine used for decades in Europe called ambroxol has shown promise for treating dementia in people with Parkinson's disease. | Drug Discovery And Development

Common cough medicine revealed to slow down Parkinson's disease and dementia

Cough Medicine Shows Promise in Slowing Parkinson’s Dementia

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia. The 12-month study found that the drug stabilized psychiatric symptoms, protected against brain damage, and even improved cognition in genetically at-risk participants.